USA
Acceder
Cotización de Agios Pharmaceuticals, Inc. (AGIO) hoy en tiempo real
Análisis técnico y gráfico histórico de Agios Pharmaceuticals, Inc.
Análisis fundamental y estadísticas clave de Agios Pharmaceuticals, Inc.
Ficha de Agios Pharmaceuticals, Inc. (AGIO)
| Ticker | AGIO |
|---|---|
| ISIN | US00847X1046 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Análisis financiero de Agios Pharmaceuticals, Inc.
Resumen financiero e información corporativa de Agios Pharmaceuticals, Inc.
Ratios de valoración: PER, EV/EBITDA y métricas de Agios Pharmaceuticals, Inc.
Márgenes de rentabilidad y Cash Flow de Agios Pharmaceuticals, Inc.
BPA, Dividendos y Valor Contable: Métricas por acción de Agios Pharmaceuticals, Inc.
Solvencia y deuda: Análisis del balance de Agios Pharmaceuticals, Inc.
Ratios de liquidez y Test Ácido: Capacidad de pago de Agios Pharmaceuticals, Inc.
Invertir en Agios Pharmaceuticals, Inc. en 2026: Preguntas frecuentes
¿Qué es Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 an...
¿En qué sector opera Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. opera en el sector Healthcare, industria Biotechnology.